Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...
Researchers have determined that metabolic and bariatric surgery (MBS) improves patient outcomes in rheumatic diseases. A recent study was conducted by Kevlin de Souza and colleagues which ...